Xilio Therapeutics (XLO) Stock Chart & Stock Price History → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free XLO Stock Alerts $1.05 +0.03 (+2.94%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Xilio Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance-13.22%3 Month Performance+26.51%6 Month Performance+23.91%Year-To-Date Performance+90.91%1 Year Performance-65.12% Receive XLO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad HedgeyeNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY XLO Stock Chart for Saturday, June, 8, 2024 XLO Chart by TradingView Xilio Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$1.02$1.05+2.94%$1.06$0.987.18 million shs$38.76 million06/06/2024$1.02$1.02$1.07$1.00102,711 shs$37.65 million06/05/2024$1.08$1.02-5.56%$1.07$0.98169,160 shs$37.65 million06/04/2024$1.05$1.08+2.86%$1.10$1.05124,068 shs$39.86 million06/03/2024$1.08$1.05-2.78%$1.09$0.98182,236 shs$38.76 million05/31/2024$0.93$1.08+16.12%$1.09$0.88228,582 shs$39.86 million Get the Latest News and Ratings for XLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$0.94$0.93-0.63%$0.94$0.86219,508 shs$34.33 million05/29/2024$0.92$0.94+2.04%$0.94$0.86175,441 shs$34.55 million05/28/2024$1.05$0.92-12.64%$1.11$0.84633,057 shs$33.86 million05/27/2024$1.05$1.05$1.12$1.03111,300 shs$38.76 million05/24/2024$1.07$1.05-1.87%$1.12$1.03111,124 shs$38.76 million05/23/2024$1.15$1.07-6.96%$1.15$1.0652,613 shs$39.49 million05/22/2024$1.20$1.15-4.17%$1.18$1.06315,181 shs$42.45 million05/21/2024$1.25$1.20-4.00%$1.26$1.1852,456 shs$44.29 million05/20/2024$1.14$1.25+9.65%$1.30$1.06340,679 shs$46.14 million05/17/2024$1.08$1.14+5.56%$1.18$1.06116,563 shs$42.08 million05/16/2024$1.12$1.08-3.57%$1.14$1.04222,872 shs$39.86 million05/15/2024$1.09$1.12+2.75%$1.15$1.09117,733 shs$41.34 million05/14/2024$1.12$1.09-2.68%$1.14$1.06125,352 shs$40.23 million05/13/2024$1.18$1.12-5.08%$1.18$1.01273,595 shs$41.34 million05/10/2024$1.26$1.18-6.35%$1.30$1.11229,366 shs$43.55 million05/09/2024$1.21$1.26+4.13%$1.32$1.16216,726 shs$46.51 million05/08/2024$1.26$1.21-3.97%$1.29$1.16157,661 shs$44.66 million05/07/2024$1.25$1.26+0.80%$1.29$1.2598,764 shs$46.51 million05/06/2024$1.18$1.25+5.93%$1.28$1.18284,729 shs$46.14 million05/03/2024$1.05$1.18+12.38%$1.22$1.04265,011 shs$43.55 million05/02/2024$1.08$1.05-2.78%$1.12$1.04182,804 shs$38.76 million05/01/2024$1.04$1.08+3.85%$1.13$1.01225,276 shs$39.86 million04/30/2024$1.04$1.04$1.08$1.01100,113 shs$38.39 million04/29/2024$1.09$1.04-4.59%$1.15$1.01377,744 shs$38.39 million04/26/2024$1.01$1.09+7.92%$1.11$1.02143,939 shs$37.57 million04/25/2024$1.06$1.01-4.72%$1.08$0.95239,349 shs$34.82 million04/24/2024$1.05$1.06+0.95%$1.11$1.01297,031 shs$36.54 million04/23/2024$1.10$1.05-4.55%$1.15$1.01445,863 shs$36.19 million04/22/2024$1.15$1.10-4.35%$1.18$1.05254,313 shs$37.92 million04/19/2024$1.28$1.15-10.16%$1.28$1.12338,694 shs$39.64 million04/18/2024$1.23$1.28+4.07%$1.28$1.20153,082 shs$44.13 million04/17/2024$1.30$1.23-5.38%$1.34$1.22437,407 shs$42.40 million04/16/2024$1.26$1.30+3.17%$1.38$1.22324,519 shs$44.81 million04/15/2024$1.18$1.26+6.78%$1.29$1.19268,617 shs$43.43 millionTrump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024.04/12/2024$1.36$1.18-13.24%$1.34$1.18499,960 shs$40.68 million04/11/2024$1.28$1.36+6.25%$1.40$1.26391,248 shs$46.88 million04/10/2024$1.31$1.28-2.29%$1.36$1.27413,402 shs$44.12 million04/09/2024$1.47$1.31-10.88%$1.49$1.31409,377 shs$45.16 million04/08/2024$1.20$1.47+22.50%$1.55$1.161.73 million shs$50.68 million04/05/2024$1.21$1.20-0.83%$1.30$1.14673,578 shs$41.36 million04/04/2024$1.30$1.21-6.92%$1.34$1.18844,045 shs$33.41 million04/03/2024$1.48$1.30-12.16%$1.47$1.112.29 million shs$35.89 million04/02/2024$1.53$1.48-3.27%$1.61$1.333.01 million shs$40.76 million04/01/2024$1.08$1.53+41.67%$1.63$1.1421.13 million shs$42.14 million03/29/2024$1.08$1.08$1.93$1.0534.54 million shs$29.75 million03/28/2024$0.64$1.08+69.01%$1.93$1.0634.38 million shs$29.74 million03/27/2024$0.66$0.64-3.08%$0.67$0.58174,118 shs$17.60 million03/26/2024$0.70$0.66-5.80%$0.71$0.6481,052 shs$18.16 million03/25/2024$0.71$0.70-1.07%$0.71$0.6748,616 shs$19.28 million03/22/2024$0.70$0.71+0.71%$0.74$0.65114,405 shs$19.49 million03/21/2024$0.69$0.70+1.66%$0.75$0.7066,397 shs$19.35 million03/20/2024$0.69$0.69+0.88%$0.73$0.6824,219 shs$19.03 million03/19/2024$0.68$0.69+0.93%$0.73$0.6546,684 shs$18.87 million03/18/2024$0.69$0.68-0.92%$0.72$0.6486,392 shs$18.69 million03/15/2024$0.65$0.69+5.94%$0.69$0.6385,834 shs$18.87 million03/14/2024$0.70$0.65-7.63%$0.76$0.61244,360 shs$17.81 million03/13/2024$0.67$0.70+4.40%$0.72$0.65172,647 shs$19.28 million03/12/2024$0.76$0.67-11.40%$0.79$0.65398,129 shs$18.47 million03/11/2024$0.83$0.76-8.82%$0.85$0.70362,279 shs$20.84 million03/08/2024$0.80$0.83+3.88%$0.89$0.7868,824 shs$22.86 million03/07/2024$0.82$0.80-2.56%$0.91$0.77410,043 shs$22.00 million Related Companies: PRQR Stock Chart MCRB Stock Chart RGLS Stock Chart CNTX Stock Chart VERU Stock Chart RPTX Stock Chart CYBN Stock Chart SCPH Stock Chart RAPT Stock Chart SYRS Stock Chart Receive XLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:XLO) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredTime is Running Out - June 25th Deadline Approaching!If you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xilio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.